Femto Technologies Secures $17 Million Investment to Advance Feminine Wellness Technology

Femto Technologies Inc., a FemTech pioneer, has secured $17 million through a private placement investment, positioning the company to advance its innovative feminine wellness technologies. The company will issue common shares and warrants to institutional investors at $4.17 per common unit, with the transaction expected to close on February 27, 2025. This substantial funding round represents a significant vote of confidence in Femto's technological approach to feminine wellness and underscores the growing investor interest in the FemTech sector.

The investment structure includes the sale of common units comprising common shares, Series A warrants, and Series B PIPE common warrants. Series A warrants will have an initial exercise price of $5.21 per common share and expire 60 months after issuance, while Series B warrants will have an initial exercise price of $12.51 per common share and expire 30 months after issuance. This multi-tiered warrant structure provides investors with both short-term and long-term participation opportunities in Femto's growth trajectory while offering the company flexible capital options for future expansion.

Femto plans to utilize the net proceeds from the offering for general corporate purposes and working capital. The primary allocation of funds will support further development of Sensera, the company's flagship feminine wellness device that integrates proprietary Smart Release System technology featuring machine learning and artificial intelligence. This strategic investment enables Femto to accelerate research and development efforts while scaling manufacturing capabilities for its innovative product line.

The Sensera device represents Femto's commitment to bridging gaps in feminine wellness through advanced technological solutions. The device recently received a CES Innovation Awards 2025 Honorary designation in the AI category, recognizing its innovative approach to women's health technology. Designed to provide a holistic self-care experience that adapts to women's changing needs, Sensera exemplifies the convergence of artificial intelligence and personalized wellness solutions in the rapidly evolving FemTech landscape.

Aegis Capital Corp. is serving as the exclusive placement agent for this private placement. The securities are being offered solely to accredited investors in a private transaction not involving a public offering, and have not been registered under the Securities Act of 1933. This financial milestone underscores Femto Technologies' strategic positioning in the emerging FemTech market, signaling continued innovation and potential growth in female wellness technologies as the sector gains increasing recognition and investment attention.